Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-05-20

Clinical Trial Update: Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

View source ↗

Summary

An in vitro study assesses how edoxaban influences coagulability and thrombin generation using thrombelastography, with relevance to heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Savaysa (edoxaban)

Snippet

Sponsor: LifeBridge Health | Conditions: Heart Failure | Status: UNKNOWN